Nitrite Measured in Cell-Based System Using Plate Reader - 2061-04_Inhibitor_Dose_DryPowder_Activity - BioAssay Summary
Cytokine induced apoptosis leads to downstream activation of nitric oxide synthase (NOS). NOS generates nitrites which are then released into the culture media by cells. The Griess reagent is a colorimetric assay for nitrites, and nitrates that have been reduced to nitrites, with a low level of detection. INS-1E cells will be treated with cytokines for 48 hours in the presence of compounds. Nitrite levels will be measured by absorbance. ..more
_
   
 Tested Compounds
 Tested Compounds
All(35)
 
 
Active(7)
 
 
Inactive(28)
 
 
 Tested Substances
 Tested Substances
All(35)
 
 
Active(7)
 
 
Inactive(28)
 
 
AID: 488866
Data Source: Broad Institute (2061-04_Inhibitor_Dose_DryPowder_Activity)
BioAssay Type: Confirmatory, Concentration-Response Relationship Observed
Depositor Category: NIH Molecular Libraries Probe Production Network
BioAssay Version:
Deposit Date: 2010-10-22
Hold-until Date: 2011-06-13
Modify Date: 2011-06-13

Data Table (Complete):           Active    All
BioActive Compounds: 7
Depositor Specified Assays
AIDNameTypeComment
435007Summary of Broad Institute MLPCN Beta Cell Apoptosis Inhibition ProjectsummarySummary assay
Description:
Keywords: nitrite production, Griess reagent, INS-1E cells, cytokine-induced apoptosis

Assay Overview:
Cytokine induced apoptosis leads to downstream activation of nitric oxide synthase (NOS). NOS generates nitrites which are then released into the culture media by cells. The Griess reagent is a colorimetric assay for nitrites, and nitrates that have been reduced to nitrites, with a low level of detection. INS-1E cells will be treated with cytokines for 48 hours in the presence of compounds. Nitrite levels will be measured by absorbance.
Protocol
Protocol:
INS-1E cells were seeded at 10,000 cells/well using a Multidrop Combi (Thermo Labsystems) in clear 384-well tissue culture plates (Corning Life Sciences).

After overnight incubation, phenol-red free plating medium containing a combination of cytokines (10 ng/mL IL-1b, 50 ng/mL IFN-g, 25 ng/mL TNF-a) was added to every well. Using libraries of compounds dissolved in DMSO and a CyBi-Well pin-transfer robot (CyBio Corp.), 0.1 uL of each compound was added to the wells.

After treatment with cytokine and compounds for 48hr, 10 uL modified Griess reagent (1:1 mixture of 1% sulfanilamide in 30% acetic acid and 0.1% N-(1-naphthyl) ethylenediamine dihydrochloride in 60% acetic acid) was added to each well.

After 5-min incubation at room temperature, the absorbance at 540 nm was measured using an Envision plate reader (PerkinElmer).
Comment
PRESENCE OF CONTROLS: Neutral control wells (NC) were included on every plate.

EXPECTED OUTCOME: Active compounds result in decreasing readout signal.

ACTIVE CONCENTRATION LIMIT:
For each sample, the highest valid tested concentration (HVC) was determined and the active concentration limit (AC_limit) was set to equal (10)(HVC).

NORMALIZATION:
The raw signals of the plate wells were normalized using the 'Neutral Controls' method in Genedata Assay Analyzer (v7.0.3):
The median raw signal of the intraplate neutral controls (NC) is set to a normalized activity value of 0.
A normalized activity value of 100 is defined as (2)(NC).
A normalized activity value of -50 is defined as (0.5)(NC).
Experimental wells values were scaled to this range.

PATTERN CORRECTION: The plate pattern correction algorithm 'Runwise Pattern (Multiplicative)' in Genedata (v7.0.3) was applied to the normalized plate data.

MEASUREMENT USED TO DETERMINE ACTIVE CONCENTRATION(AC): AC50
AC values were calculated using the curve fitting strategies in Genedata Screener Condoseo (7.0.3).
AC values were calculated up to the active concentration limit described for each sample.

PUBCHEM_ACTIVITY_OUTCOME:
Activity_Outcome = 1 (inactive) when:
a) curve fit is constant where activity is > -30% and < 30% at all tested concentrations, or
b) AC > AC_limit, or
c) compound shows activity but in a direction opposite to the expected outcome
in these cases, values describing curve fitting parameters (Sinf, S0, Hill Slope, log_AC50, log_AC50_SE) are set to null

Activity_Outcome = 2 (active) when:
AC <= AC_limit

Activity_Outcome = 3 (inconclusive) when:
a) Curve fitting strategy resulted in a constant fit with activity >= -70% but <= -30%, or
b) The fit was not valid due to poor fit quality.

PUBCHEM_ACTIVITY_SCORE:

PUBCHEM_ACTIVITY_SCORE = 0 when PUBCHEM_ACTIVITY_OUTCOME = 1 (inactive) or 3 (inconclusive)

PUBCHEM_ACTIVITY_SCORE = (-10)[Log(AC)], where AC is in molar, when PUBCHEM_ACTIVITY_OUTCOME = 2 (active)
Scores relate to AC in this manner:

120 = 1 pM
90 = 1 nM
60 = 1 uM
30 = 1 mM
0 = 1 M

PUBCHEM_ACTIVITY_SCORE = 100 when the curve fit is constant and showing full inhibition at all tested concentrations.


NOTE:

The individual dose data point columns ('Activity_at_xxuM') reported here represent the median of valid (unmasked) replicate observations at each concentration. These values are the inputs to a curve fitting algorithm.

All other data columns represent values which are derived during the curve fitting algorithm; this may sometimes include automatic further masking of some replicate data points.
Occasionally this results in perceived inconsistencies: for example, between the derived 'Maximal_Activity' and the apparent most active data point.
Result Definitions
Show more
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1AC50_Qualifier'>','=', or '<'String
2AC50_uM*The concentration at which activity reaches 50% of the maximumFloatμM
3Log_AC50_MThe log of the molar AC50Float
4Log_AC50_M_Standard_ErrorThe standard error for the log of the molar AC50 valueFloat
5Hill_SlopeThe slope at AC50Float
6S0The fitted activity value at zero concentrationFloat%
7SinfThe fitted activity value at infinite concentrationFloat%
8Num_PointsThe number of data points used to generate the plotInteger
9Max_ActivityThe maximum activity value observed, based on mean of replicates per concentrationFloat%
10Max_Activity_Conc_uMThe concentration at which the maximum activity is observedFloatμM
11Activity_at_0.16uM (0.16μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
12Activity_at_0.3uM (0.3μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
13Activity_at_0.6uM (0.6μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
14Activity_at_0.68uM (0.68μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
15Activity_at_1.2uM (1.2μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
16Activity_at_1.35uM (1.35μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
17Activity_at_2.6uM (2.6μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
18Activity_at_5uM (5μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
19Activity_at_10uM (10μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
20Activity_at_19.5uM (19.5μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
21Activity_at_21uM (21μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%

* Activity Concentration. ** Test Concentration.
Additional Information
Grant Number: DP2 DK083048

Data Table (Concise)
PageFrom: